Your support fuels our research to #EndALS! Donate Now

ALS News & Stories

Welcome to the ALS TDI news page. View our research news, press releases and blogs below. To find out more about our organization or to contact our team, visit our press room here.

ALS News & Stories

Welcome to the ALS TDI news page. View our research news, press releases and blogs below. To find out more about our organization or to contact our team, visit our press room here.

ALS Research News

Monday, August 1, 2022
ALS TDI's 2022 Mid-Year Highlights
We are proud of the progress that we have made thus far in 2022 and we look forward to continuing to share detailed updates at the 2022 ALS TDI Summit on October 14th.
read more
Monday, July 18, 2022
What Clinical Trials are Recruiting Right Now?
A list of phase 3 clinical trials recruiting in the United States as of July 2022.
read more
Wednesday, June 29, 2022
Dr. Ammar Al-Chalabi: Why the Terms “familial” and “sporadic” ALS can be Misleading
Many in the ALS research community believe that, in light of what we now know about the disease, these terms are not entirely accurate.
read more
From trial readouts to news from our lab, you can find all of the latest ALS research news here.

ALS TDI Community Blog

Monday, September 26, 2022
Announcing our Guest Speakers for the 2022 ALS TDI Summit
ALS TDI will welcome several leaders from across the ALS research and drug development community to share updates about new research, treatments in the clinical pipeline, and more.
read more
Thursday, September 22, 2022
Michele Dupree to Serve as VIP Concierge for people with ALS at ALS TDI’s Leadership Weekend in October
Earlier this year, Michele Dupree joined the ALS Therapy Development Institute (ALS TDI) as a Develo
read more
Wednesday, September 7, 2022
Rebecca Mourey, Lori Larson Heller, Sandra Marlowe, and Her ALS Story receive Leadership Awards
The ALS Therapy Development Institute (ALS TDI) is proud to announce the 2022 Leadership Award recipients
read more
Blog posts and commentary pieces from ALS TDI and community members with topics ranging from funding ALS research to how ALS impacts the lives of community members.

ALS TDI Press Releases

Wednesday, September 28, 2022
ALS Therapy Development Institute Announces Superior Rail & Iron Works, Inc. as First Title Sponsor of White Coat Affair Gala
Superior Rail & Iron Works, Inc. will be the first Title Sponsor of the White Coat Affair gala, being held on October 15, 2022, at the Boston Sheraton to raise funds for ALS research.
read more
Tuesday, March 1, 2022
Tegoprubart: AT-1501’s New Name
AT-1501, a drug invented at the ALS Therapy Development Institute (ALS TDI) and being developed by Eledon Pharmaceuticals, has a new name: tegoprubart.
read more
A complete list of press releases from the ALS Therapy Development Institute.
Follow Us
Learn more about our team, what what we're working on in the lab, and our amazing community by following us on social media!
Media Contact
We'd love to share our story with you. Speak to our team about our unique approach to end ALS.